The S&P 500 ended Friday down a mere fraction of a point. The three major US stock indexes posted a second straight week of gains after a correction that evaporated following a brief drop of 4 per cent.
An escalation of the conflict in eastern Ukraine will likely bring stronger economic sanctions against Russia from Europe and the United States - and harsher retaliation from Moscow. Business sentiment is already on edge in Germany as Europe's largest economy deals with reduced trade with Russia. An index of Russian equities has dropped 6 per cent for the year so far. Against that backdrop, US stocks - backed by earnings - still look like the best option for investors in developed markets.
US-based stock funds that invest in European equities have marked nine straight weeks of outflows, according to Lipper, a Thomson Reuters company. Flows into US stock funds in that time have come to about $3 billion.
During the selloff on Friday, the utilities sector remained strong, rivaled only by energy stocks, with investors focusing on high-dividend payers as US Treasury bond yields fell.
Looking forward, though, unless something else happens to upset markets, investors seem more focused on the re-emergence of leadership from the healthcare, biotechnology and tech sectors. The Nasdaq Biotech Index ended Friday up 0.9 per cent, gaining 4.6 per cent for the week.
Brian Reynolds, chief market strategist at Rosenblatt Securities in New York, believes tech, healthcare and large-cap biotechs are in position to lead the US stock market higher for the next several weeks. He sees the S&P 500 rising on Monday if tensions do not become worse.
"If Russia does not escalate, stocks are likely to open above the 1,960 they were at earlier today as people who put on knee-jerk shorts cover," he wrote late on Friday.
At a 4.6 per cent rate, revenue growth for S&P 500 companies is expected to be higher than estimates going back to October last year. Even as economic figures remain somewhat mixed, investors still remain positive about overall US demand.
"These are horrible human tragedies and that's worthy of mention every time this comes up," said Lawrence Creatura, portfolio manager at Federated Investors in Rochester, New York. "However, the economic impact (in the United States) has been small."
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)